<DOC>
	<DOCNO>NCT00188942</DOCNO>
	<brief_summary>This study employ functional magnetic resonance imaging compare brain activation pattern depressive episode patient diagnose bipolar disorder , major depressive disorder , group healthy control subject . Depressed patient treat combination fluoxetine olanzapine undergo MRI scan , , pharmacotherapy .</brief_summary>
	<brief_title>A Neuroimaging Investigation Brain Activity Major Depressive Disorder Bipolar Disorder</brief_title>
	<detailed_description>The purpose study characterize neural correlate affective processing BD MDD subject use fMRI . Subjects meet criterion major depressive episode context BD ( n=15 ) ; MDD ( n=15 ) group psychiatrically unaffected control subject ( CS , n=15 ) undergo four fMRI scan experience temporary mood induction presentation affective imagery International Affective Picture System ( IAPS ) . Both BD MDD subject receive combination pharmacotherapy treat depression , fMRI data acquire , 1 , 3 , 6 week follow pharmacotherapy initiation . Positive , negative , neutral affective visual stimulus present blocked design . Comparison ( ) : The effect time group analyze factorial model . Regions interest demonstrate significant group-by-time interaction correlate self-report clinician-rated psychometric index .</detailed_description>
	<mesh_term>Disease</mesh_term>
	<mesh_term>Depressive Disorder</mesh_term>
	<mesh_term>Depression</mesh_term>
	<mesh_term>Depressive Disorder , Major</mesh_term>
	<mesh_term>Fluoxetine</mesh_term>
	<mesh_term>Olanzapine</mesh_term>
	<criteria>( All three group ) age 1855 year satisfactory physical health education level degree understand communicate effectively investigator c capable providing inform consent female subject childbearing potential , medically accept mean contraception . Additional inclusion criterion patient group include DSMIVTR criterion diagnosis BD MDD currently meet criterion MDE Hamilton Depression Rating Scale 17 Item ( HDRS17 ) score &gt; 17 blood index within normal clinical range . ( All three group ) DSMIVTR criterion substance abuse dependence ( except nicotine caffeine ) within past 6 month comorbid neurological major psychiatric disorder define DSMIVTR ; history neurological trauma result loss consciousness ; uncorrected hypothyroidism hyperthyroidism , include elevate thyroid stimulate hormone ( TSH ) ; unstable medical condition ; female subject pregnant nursing ; Additional exclusion criterion BD MDD group include : prior failure respond fluoxetine olanzapine combination adequate dose duration ; evidence serious risk suicide base clinician assessment and/or HRSD suicide item &gt; 3 ; course ECT ( electroconvulsive therapy ) precede 6 month ; Young Mania Rating Scale ( YMRS ) &gt; 7 ; administration fluoxetine within previous 4 week ; treatment resistance define failure two antidepressant trial dissimilar class Hyperglycemia diabetes mellitus define fast blood glucose value &gt; 125 mg/dl .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>February 2013</verification_date>
	<keyword>Magnetic Resonance Imaging</keyword>
	<keyword>Diagnostic Imaging</keyword>
	<keyword>Mood Disorders</keyword>
	<keyword>Major Depressive Disorder</keyword>
	<keyword>Antipsychotic</keyword>
	<keyword>Olanzapine</keyword>
	<keyword>Fluoxetine</keyword>
</DOC>